CN103298828A - 犹他游动放线菌的基因组学 - Google Patents
犹他游动放线菌的基因组学 Download PDFInfo
- Publication number
- CN103298828A CN103298828A CN2011800482846A CN201180048284A CN103298828A CN 103298828 A CN103298828 A CN 103298828A CN 2011800482846 A CN2011800482846 A CN 2011800482846A CN 201180048284 A CN201180048284 A CN 201180048284A CN 103298828 A CN103298828 A CN 103298828A
- Authority
- CN
- China
- Prior art keywords
- gene
- sequence
- dna
- genome
- wild type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000187840 Actinoplanes utahensis Species 0.000 title description 35
- 238000000034 method Methods 0.000 claims abstract description 17
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 claims description 26
- 229960002632 acarbose Drugs 0.000 claims description 26
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 claims description 26
- 230000008859 change Effects 0.000 claims description 14
- 239000012634 fragment Substances 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 81
- 238000004519 manufacturing process Methods 0.000 abstract description 21
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 5
- 238000012239 gene modification Methods 0.000 abstract description 4
- 230000005017 genetic modification Effects 0.000 abstract description 4
- 235000013617 genetically modified food Nutrition 0.000 abstract description 4
- 238000012986 modification Methods 0.000 abstract description 4
- 230000004048 modification Effects 0.000 abstract description 4
- 230000003505 mutagenic effect Effects 0.000 abstract description 4
- 231100000219 mutagenic Toxicity 0.000 abstract description 3
- 238000012512 characterization method Methods 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 description 45
- 108020004414 DNA Proteins 0.000 description 18
- 238000012163 sequencing technique Methods 0.000 description 14
- 231100000350 mutagenesis Toxicity 0.000 description 11
- 239000002773 nucleotide Substances 0.000 description 11
- 125000003729 nucleotide group Chemical group 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 10
- 238000002703 mutagenesis Methods 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 239000004927 clay Substances 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 230000008034 disappearance Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 125000003275 alpha amino acid group Chemical group 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000013507 mapping Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 241000187844 Actinoplanes Species 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 102000040739 Secretory proteins Human genes 0.000 description 3
- 108091058545 Secretory proteins Proteins 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000007474 Multiprotein Complexes Human genes 0.000 description 2
- 108010085220 Multiprotein Complexes Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- 101150036080 at gene Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000005314 correlation function Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000012268 genome sequencing Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 108091005703 transmembrane proteins Proteins 0.000 description 2
- 102000035160 transmembrane proteins Human genes 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- NOIRDLRUNWIUMX-UHFFFAOYSA-N 2-amino-3,7-dihydropurin-6-one;6-amino-1h-pyrimidin-2-one Chemical compound NC=1C=CNC(=O)N=1.O=C1NC(N)=NC2=C1NC=N2 NOIRDLRUNWIUMX-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241001156739 Actinobacteria <phylum> Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108091029795 Intergenic region Proteins 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 102000002278 Ribosomal Proteins Human genes 0.000 description 1
- 108010000605 Ribosomal Proteins Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000008579 Transposases Human genes 0.000 description 1
- 108010020764 Transposases Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 101150036253 acbC gene Proteins 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008275 binding mechanism Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 108010064866 biozym Proteins 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010205 computational analysis Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000007030 peptide scission Effects 0.000 description 1
- 108010022393 phosphogluconate dehydratase Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000037432 silent mutation Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 150000003608 titanium Chemical class 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/365—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinoplanes (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/12—Unicellular algae; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Botany (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Developing Agents For Electrophotography (AREA)
- Peptides Or Proteins (AREA)
- Detergent Compositions (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (3)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10171831 | 2010-08-04 | ||
EP10171831.0 | 2010-08-04 | ||
PCT/EP2011/063243 WO2012016960A1 (en) | 2010-08-04 | 2011-08-01 | Genomics of actinoplanes utahensis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103298828A true CN103298828A (zh) | 2013-09-11 |
CN103298828B CN103298828B (zh) | 2016-08-03 |
Family
ID=44629912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180048284.6A Active CN103298828B (zh) | 2010-08-04 | 2011-08-01 | 犹他游动放线菌的基因组学 |
Country Status (10)
Country | Link |
---|---|
US (1) | US9719064B2 (zh) |
EP (1) | EP2601209B1 (zh) |
JP (3) | JP6332966B2 (zh) |
KR (1) | KR20160073433A (zh) |
CN (1) | CN103298828B (zh) |
CA (1) | CA2807264A1 (zh) |
ES (1) | ES2625773T3 (zh) |
HK (1) | HK1184796A1 (zh) |
TW (1) | TW201217533A (zh) |
WO (1) | WO2012016960A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110914912A (zh) * | 2017-06-06 | 2020-03-24 | 齐默尔根公司 | 对基因修饰进行优先级排序以增加表型优化的吞吐量 |
WO2021073900A1 (en) | 2019-10-16 | 2021-04-22 | Bayer Aktiengesellschaft | Methods for the improved formation of acarbose |
WO2023208146A1 (zh) * | 2022-04-27 | 2023-11-02 | 武汉合生科技有限公司 | 生物合成麦角硫因的方法及载体 |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201217533A (en) * | 2010-08-04 | 2012-05-01 | Bayer Pharma AG | Genomics of actinoplanes utahensis |
ES2718331T3 (es) * | 2011-12-08 | 2019-07-01 | Bayer Ip Gmbh | Nuevo elemento integrador y conjugador de actinomiceto de Actinoplanes sp. SE50/110 como plásmido para la transformación genética de actinobacterias relacionadas |
US9421199B2 (en) | 2014-06-24 | 2016-08-23 | Sydnexis, Inc. | Ophthalmic composition |
WO2016172712A2 (en) | 2015-04-23 | 2016-10-27 | Sydnexis, Inc. | Ophthalmic composition |
US11382909B2 (en) | 2014-09-05 | 2022-07-12 | Sydnexis, Inc. | Ophthalmic composition |
EP3302426A4 (en) | 2015-05-29 | 2018-12-05 | Sydnexis, Inc. | D2o stabilized pharmaceutical formulations |
WO2017196795A2 (en) * | 2016-05-09 | 2017-11-16 | The Rockefeller University | Bioactive metabolites encoded by the human microbiome using primary sequence alone |
WO2018169926A1 (en) * | 2017-03-14 | 2018-09-20 | Oregon State University | Peptide inhibitors targeting the neisseria gonorrhoeae pivotal anaerobic respiration factor ania |
CN108624544B (zh) * | 2017-03-20 | 2021-08-27 | 浙江海正药业股份有限公司 | 阿卡波糖工程菌及其制备方法和应用 |
US20230371483A1 (en) * | 2019-07-25 | 2023-11-23 | The Regents Of The University Of California | Methods and compositions for sexing and sterilization in drosophila suzukii and aedes aegypti |
CN112903657B (zh) * | 2021-01-28 | 2022-06-24 | 中山大学 | 一种三聚氰胺和甲醛的表面增强拉曼光谱检测方法 |
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1249001A (zh) * | 1997-02-28 | 2000-03-29 | 拜尔公司 | 来自游动放线菌SE50/110的Acarboseacb基因簇 |
DE10021667A1 (de) * | 2000-05-05 | 2001-11-08 | Bayer Ag | Neue Enzyme in der Acarbose-Synthese und deren Verwendung |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7630836B2 (en) * | 2001-05-30 | 2009-12-08 | The Kitasato Institute | Polynucleotides |
TW201217533A (en) * | 2010-08-04 | 2012-05-01 | Bayer Pharma AG | Genomics of actinoplanes utahensis |
-
2011
- 2011-07-28 TW TW100126698A patent/TW201217533A/zh unknown
- 2011-08-01 ES ES11741187T patent/ES2625773T3/es active Active
- 2011-08-01 CA CA2807264A patent/CA2807264A1/en not_active Abandoned
- 2011-08-01 WO PCT/EP2011/063243 patent/WO2012016960A1/en active Application Filing
- 2011-08-01 CN CN201180048284.6A patent/CN103298828B/zh active Active
- 2011-08-01 US US13/814,235 patent/US9719064B2/en active Active
- 2011-08-01 JP JP2013522225A patent/JP6332966B2/ja active Active
- 2011-08-01 KR KR1020137005236A patent/KR20160073433A/ko not_active Application Discontinuation
- 2011-08-01 EP EP11741187.6A patent/EP2601209B1/en active Active
-
2013
- 2013-11-01 HK HK13112299.8A patent/HK1184796A1/zh unknown
-
2016
- 2016-11-22 JP JP2016226705A patent/JP6449214B2/ja active Active
-
2018
- 2018-10-17 JP JP2018195488A patent/JP6700365B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1249001A (zh) * | 1997-02-28 | 2000-03-29 | 拜尔公司 | 来自游动放线菌SE50/110的Acarboseacb基因簇 |
DE10021667A1 (de) * | 2000-05-05 | 2001-11-08 | Bayer Ag | Neue Enzyme in der Acarbose-Synthese und deren Verwendung |
Non-Patent Citations (1)
Title |
---|
CHANG-GU HYUN ET AL.: "molecular detection of alpha-glucosidase inhibitor-producing actinomycetes", 《THE JOURNAL OF MICROBIOLOGY》, vol. 43, no. 3, 30 June 2005 (2005-06-30), pages 313 - 318, XP002660585 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110914912A (zh) * | 2017-06-06 | 2020-03-24 | 齐默尔根公司 | 对基因修饰进行优先级排序以增加表型优化的吞吐量 |
WO2021073900A1 (en) | 2019-10-16 | 2021-04-22 | Bayer Aktiengesellschaft | Methods for the improved formation of acarbose |
WO2023208146A1 (zh) * | 2022-04-27 | 2023-11-02 | 武汉合生科技有限公司 | 生物合成麦角硫因的方法及载体 |
Also Published As
Publication number | Publication date |
---|---|
CN103298828B (zh) | 2016-08-03 |
JP2013535206A (ja) | 2013-09-12 |
HK1184796A1 (zh) | 2014-01-30 |
ES2625773T3 (es) | 2017-07-20 |
US9719064B2 (en) | 2017-08-01 |
KR20160073433A (ko) | 2016-06-27 |
WO2012016960A1 (en) | 2012-02-09 |
JP6332966B2 (ja) | 2018-06-06 |
EP2601209A1 (en) | 2013-06-12 |
US20130302855A1 (en) | 2013-11-14 |
EP2601209B1 (en) | 2017-03-01 |
JP2017060500A (ja) | 2017-03-30 |
JP6449214B2 (ja) | 2019-01-09 |
JP2019030317A (ja) | 2019-02-28 |
JP6700365B2 (ja) | 2020-05-27 |
TW201217533A (en) | 2012-05-01 |
CA2807264A1 (en) | 2012-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103298828A (zh) | 犹他游动放线菌的基因组学 | |
Salazar et al. | Nanopore sequencing enables near-complete de novo assembly of Saccharomyces cerevisiae reference strain CEN. PK113-7D | |
Leao et al. | Comparative genomics uncovers the prolific and distinctive metabolic potential of the cyanobacterial genus Moorea | |
Ichikawa et al. | Genome sequence of Kitasatospora setae NBRC 14216T: an evolutionary snapshot of the family Streptomycetaceae | |
Berube et al. | Emergence of trait variability through the lens of nitrogen assimilation in Prochlorococcus | |
Nolling et al. | Genome sequence and comparative analysis of the solvent-producing bacterium Clostridium acetobutylicum | |
Thanassi et al. | Identification of 113 conserved essential genes using a high‐throughput gene disruption system in Streptococcus pneumoniae | |
Youssef et al. | Partial genome assembly for a candidate division OP11 single cell from an anoxic spring (Zodletone Spring, Oklahoma) | |
Schwientek et al. | The complete genome sequence of the acarbose producer Actinoplanes sp. SE50/110 | |
Doxey et al. | Discovery of novel bacterial toxins by genomics and computational biology | |
Hücker et al. | Discovery of numerous novel small genes in the intergenic regions of the Escherichia coli O157: H7 Sakai genome | |
Pei et al. | Systematic and functional identification of small non-coding RNAs associated with exogenous biofuel stress in cyanobacterium Synechocystis sp. PCC 6803 | |
Pfeiffer et al. | The complete and fully assembled genome sequence of Aeromonas salmonicida subsp. pectinolytica and its comparative analysis with other Aeromonas species: investigation of the mobilome in environmental and pathogenic strains | |
Frank et al. | Pseudomonas putida KT2440 genome update by cDNA sequencing and microarray transcriptomics | |
Freel et al. | Adaptation in toxic environments: arsenic genomic islands in the bacterial genus Thiomonas | |
Li et al. | Comparative genomics reveals broad genetic diversity, extensive recombination and nascent ecological adaptation in Micrococcus luteus | |
Lalanne et al. | Spurious regulatory connections dictate the expression‐fitness landscape of translation factors | |
Hayden et al. | Large-insert genome analysis technology detects structural variation in Pseudomonas aeruginosa clinical strains from cystic fibrosis patients | |
You et al. | Comparative genomics of a Helicobacter pylori isolate from a Chinese Yunnan Naxi ethnic aborigine suggests high genetic divergence and phage insertion | |
Peng et al. | An integrated approach for finding overlooked genes in Shigella | |
Volokhov et al. | Discovery of natural atypical nonhemolytic Listeria seeligeri isolates | |
Alou et al. | Massilibacterium senegalense gen. nov., sp. nov., a new bacterial genus isolated from the human gut | |
Yuan et al. | A complete genome assembly of Glaciecola mesophila sp. nov. sequenced by using BIGIS-4 sequencer system | |
Wang et al. | Comparative genomic analysis provides insight into the phylogeny and potential mechanisms of adaptive evolution of Sphingobacterium sp. CZ-2 | |
KR101165247B1 (ko) | 트리데캅틴 생합성 효소 및 이를 코딩하는 유전자 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1184796 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1184796 Country of ref document: HK |
|
CP02 | Change in the address of a patent holder |
Address after: Germany's Rhine River Monheim Patentee after: BAYER INTELLECTUAL PROPERTY GmbH Address before: Germany Patentee before: BAYER INTELLECTUAL PROPERTY GmbH |
|
CP02 | Change in the address of a patent holder |